Listed

CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2017

Filed with the SEC on Aug 8, 2017 and accepted by EDGAR at Aug 8, 2017, 07:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-04-01 to 2017-06-30$45.69bnus-gaap:Revenues
Revenue6 months2017-01-01 to 2017-06-30$90.20bnus-gaap:Revenues
Cost of revenue3 months2017-04-01 to 2017-06-30$38.75bnus-gaap:CostOfRevenue
Cost of revenue6 months2017-01-01 to 2017-06-30$76.68bnus-gaap:CostOfRevenue
Gross profit3 months2017-04-01 to 2017-06-30$6.93bnus-gaap:GrossProfit
Gross profit6 months2017-01-01 to 2017-06-30$13.52bnus-gaap:GrossProfit
Operating income3 months2017-04-01 to 2017-06-30$2.12bnus-gaap:OperatingIncomeLoss
Operating income6 months2017-01-01 to 2017-06-30$3.91bnus-gaap:OperatingIncomeLoss
Income tax3 months2017-04-01 to 2017-06-30$766.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2017-01-01 to 2017-06-30$1.34bnus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-04-01 to 2017-06-30$1.10bnus-gaap:NetIncomeLoss
Net income6 months2017-01-01 to 2017-06-30$2.05bnus-gaap:NetIncomeLoss
Diluted EPS3 months2017-04-01 to 2017-06-30$1.07us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2017-01-01 to 2017-06-30$1.98us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-04-01 to 2017-06-30$1.07us-gaap:EarningsPerShareBasic
Basic EPS6 months2017-01-01 to 2017-06-30$1.99us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-04-01 to 2017-06-301,024,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2017-01-01 to 2017-06-301,029,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2017-01-01 to 2017-06-30$5.53bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2017-01-01 to 2017-06-30$888.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2017-01-01 to 2017-06-30$1.03bnus-gaap:PaymentsOfDividends
Share repurchases6 months2017-01-01 to 2017-06-30$3.96bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-06-30$2.09bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-06-30$29.40bnus-gaap:AssetsCurrent
Total assetsAt period end2017-06-30$92.53bnus-gaap:Assets
Current liabilitiesAt period end2017-06-30$26.86bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2017-06-30$25.62bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2017-06-30$42.0mus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2017-06-30$1.10bnus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2017-06-30$34.14bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-17-006198. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.